CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma

Bookmark and Share
Published: 7 Oct 2019
Views: 192
Rating:
Save
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

Dr Ana Arance speaks to ecancer at ESMO 2019 in Barcelona about the Checkmate 067 trial.

This trial looks at nivolumab plus ipilimumab combination therapy in advanced melanoma, and at ESMO 2019 we saw the 5 year survival outcomes.